144 related articles for article (PubMed ID: 15677842)
1. Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E15-6. PubMed ID: 15677842
[TBL] [Abstract][Full Text] [Related]
2. Bichat guidelines for the clinical management of brucellosis and bioterrorism-related brucellosis.
Bossi P; Tegnell A; Baka A; van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G
Euro Surveill; 2004 Dec; 9(12):33-34. PubMed ID: 29183471
[TBL] [Abstract][Full Text] [Related]
3. Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E9-10. PubMed ID: 15677845
[TBL] [Abstract][Full Text] [Related]
4. Bichat guidelines for the clinical management of Q fever and bioterrorism-related Q fever.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E19-20. PubMed ID: 15677840
[TBL] [Abstract][Full Text] [Related]
5. Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E3-4. PubMed ID: 15677848
[TBL] [Abstract][Full Text] [Related]
6. Bichat guidelines for the clinical management of plague and bioterrorism-related plague.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E5-6. PubMed ID: 15677847
[TBL] [Abstract][Full Text] [Related]
7. Bichat guidelines for the clinical management of viral encephalitis and bioterrorism-related viral encephalitis.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E21-2. PubMed ID: 15677839
[TBL] [Abstract][Full Text] [Related]
8. Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E17-8. PubMed ID: 15677841
[TBL] [Abstract][Full Text] [Related]
9. Bichat guidelines for the clinical management of smallpox and bioterrorism-related smallpox.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E7-8. PubMed ID: 15677846
[TBL] [Abstract][Full Text] [Related]
10. Bichat clinical guidelines for bioterrorist agents.
Bossi P; Van Loock F; Tegnell A; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E1-2. PubMed ID: 15677849
[No Abstract] [Full Text] [Related]
11. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses.
Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E11-2. PubMed ID: 15677844
[TBL] [Abstract][Full Text] [Related]
12. Bichat guidelines for the clinical management of botulism and bioterrorism-related botulism.
Bossi P; Tegnell A; Baka A; van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
Euro Surveill; 2004 Dec; 9(12):E13-4. PubMed ID: 15677843
[TBL] [Abstract][Full Text] [Related]
13. Bioterrorism, Glanders and melioidosis.
Cheng AC; Dance DA; Currie BJ
Euro Surveill; 2005 Mar; 10(3):E1-2; author reply E1-2. PubMed ID: 15827368
[No Abstract] [Full Text] [Related]
14. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
Karabay O; Sencan I; Kayas D; Sahin I
BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS
Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463
[TBL] [Abstract][Full Text] [Related]
16. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
[TBL] [Abstract][Full Text] [Related]
17. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis.
Godfroid J; Cloeckaert A; Liautard JP; Kohler S; Fretin D; Walravens K; Garin-Bastuji B; Letesson JJ
Vet Res; 2005; 36(3):313-26. PubMed ID: 15845228
[TBL] [Abstract][Full Text] [Related]
18. Epidemic intelligence in the European Union: strengthening the ties.
Coulombier D
Euro Surveill; 2008 Feb; 13(6):. PubMed ID: 18445427
[No Abstract] [Full Text] [Related]
19. Implications of laboratory diagnosis on brucellosis therapy.
Al Dahouk S; Nöckler K
Expert Rev Anti Infect Ther; 2011 Jul; 9(7):833-45. PubMed ID: 21810055
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three different combination therapies in the treatment of human brucellosis.
Ersoy Y; Sonmez E; Tevfik MR; But AD
Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
